PACAP hybrid: A new PACAP receptor antagonist

Life Sciences

Volumn 61, Issue 6, 1997, Pages 631-639

  Pisegna, J R ^a   Leyton, J ^b   Coelho, T ^b   Hida, T ^b   Jakowlew, S ^b   Birrer, M ^b   Fridkin, M ^c   Gozes, I ^d   Moody, T W ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

PACAP; PACAP antagonist; Receptor; Splice variants

Indexed keywords

CALCIUM; COMPLEMENTARY DNA; CYCLIC AMP; HYBRID PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; IODINE 125; MESSENGER RNA; NEUROTENSIN[6-11]PACAP[7-38]; PACAP HYBRID; PACAP RECEPTOR ANTAGONIST; PACAP[6-38]; PEPTIDE; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CALCIUM CELL LEVEL; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; MOUSE; NONHUMAN; RNA SPLICING;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; GENES, FOS; HUMANS; IODINE RADIOISOTOPES; MICE; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN HYBRIDIZATION; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY HORMONE; RNA, MESSENGER; SEQUENCE HOMOLOGY; TRANSFECTION;

ANIMALIA;

EID: 0030786398     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00438-4     Document Type: Article

References (30)

1. S.I. SAID, and V. MUTT, Science 69 1217-1218 (1970).
2. A. MIYATA, A., AMIMURA, R. DAHL, A. UEHARA, L. JINAG, M.D. CULLER and D.H. COY, Biochem. Biophys. Res. Commun. 164 567-574 (1989).
3. A. MIYATA, L. JIANG, R.R. DAHL, C. KITADA, K. KUBO, M. FUJINO, N. MINAMINO and A. ARIMURA, Biochem. Biophys. Res. Commun. 170 643-648 (1990).
4. T.W. MOODY, F. ZIA and A. MAKHEJA, Peptides 14 241-246 (1993).
5. E. CHADSTRE, Y. DI GIOIA, S. DJELLOUL, S. EMPEREUR, C. LOUVET, A.M. COUDRAY, M.E. FORGUE-LAFITTE, J. BARA and C. GESPACH, In "VIP, PACAP and related regulatory peptides: From molecular biology to clinical application." G. Rosselin (Ed.), World Scientific, Singapore 568-576 (1994).
6. E. DICICCO-BLOOM and N. LU, In "VIP, PACAP and related regulatory peptides: From molecular biology to clinical application." G. Rosselin (Ed.), World Scientific, Singapore 593-594 (1994).
7. F. ZIA, M. FAGARASAN, K. BITAR, D.H. COY, J.R. PISEGNA, S.A. WANK, and T.W. MOODY, Cancer Res. 55 4886-4891 (1995).
8. M. DRAOUI, T. HIDA, S. JAKOWLEW, M. BIRRER, F. ZIA and T.W. MOODY, Life Sci. 59 307-313 (1996).
9. T.W. MOODY, F. ZIA, K. BITAR and D.H. COY, In "VIP, PACAP and related regulatory peptides: From molecular biology to clinical application." G. Rosselin (Ed.), World Scientific, Sinapore 537-544 (1994).
10. J.R. Pisegna and S.A. Wank, Proc. Natl. Acad. Sci. USA 90 6345-6349 (1993).
11. J. A. MORROW, E.M. LUTZ, K. WEST, G. FINK and A.J. HARMAR, FEBS Lett. 329 99-105 (1993).
12. M. SVOBODA, M. TASTENOY, E. CICCARELLI, M. STIEVENART and J. CHRISTOPHE, Biochem. Biophys. Res. Commun. 195 881-888 (1993).
13. K. OGI, Y. MIYAMOTO, Y. MASUDA, Y. HABATA, M. HOSOYA, T. OHTAKI, Y. MASUO, H. ONDA and M. FUJINO, Biochem. Biophys. Res. Commun. 196 1511-1521 (1993).
14. M. HOSOYA, H. ONDA, K. OGI, Y. MASUDA, Y. MIYAMO, T. OHTAKI, H. OKAZAKI, A. ARIMURA and M. FUJINO, Biochem. Biophys. Res. Commun. 194 133-143 (1993).
15. Y. MIYAMOTO, I. HABATA, T. OHTAKI, Y. MASUDA, K. OGI, H. ONDA, and M. FUJINO, Biochim. Biophys. Acta 1218 297-307 (1994).
16. T. ISHIHARA, R. SHIGEMOTO, K. MORI, K. TAKAHASHI and S. NAGATA, Neuron 8 811-819 (1992).
17. T. B. USDIN, T.I. BORNER and E. Mezey, Endocrinology 135 2662-2680 (1994).
18. S.P. SREEDHARAN, D.R. PATEL, J.X. HUANG and E.J. GOETZL, Biochem. Biophys. Res. Commun. 193 546-553 (1993).
19. A. COUINEAU, C. ROUYER-FESSARD, D. DARMOUL, J. MAORET, I. CARRERO, E. OGIER-DENIS, and M. LABURTHE, Biochem. Biophys. Res. Commun. 200 769-776 (1994).
20. T. HARMAR and E. LUTZ, Trends In Pharmacological Sciences 15. 97-99 (1994).
21. M. SVOBODA, M. TASTENOY, J. VAN RAMPELBERGH, F. GOOSSENS, P. DENEEF, M. WAELBROECK, and P. ROBBERECHT, Biochem. Biophys. Res. Commun. 205 1617-1624 (1994).
22. N. INAGAKI, H. YOSHIDA, M. MIZUTA, N. MIZUNO, Y. FUJII, T. GONOI, J. MIYAZAKI, and S. SEINO, Proc. Natl. Acad. Sci. USA 91 2679-2683 (1994).
23. D. SPENGLER, C. WAEBER, C. PANTALONI, F. HOLSBOER, J. BOCKAERT, P. H. SEEBERG and L. JOURNOT, Nature 365 170-175 (1993).
24. J. PISEGNA and S. WANK, J. Biol. Chem. 271 17267-17274 (1996).
25. I. GOZES, S.K. MCCUNE, L. JACOBSON, D. WARREN, T. MOODY, M. FRIDKIN and D. BRENNEMAN, J. Pharm. Exp. Ther. 257 959-966 (1991).
26. L.Y. KORMAN, D.N. CARNEY, M.L. CITRON, and T.W. MOODY, Cancer Res. 46 1214-1218 (1986).
27. Y. GOZES, D.E. BRENNEMAN, M. FRIDKIN, B. ASOFSKY and I. GOZES, Brain Res. 540 319-321 (1991).
28. T.W. MOODY, F. ZIA, D. BRENNEMAN, M. FRIDKIN, A. DAVIDSON and I. GOZES, Proc. Natl. Acad. Sci. USA 90 4345-4349 (1993).
29. P. GOURLET, M.C. WOUSSEN-COLLE, P. ROBBERECHT, P. DE NEFF, A. CAUVIN, M.C. VANDERMEERS-PIRET, A. VANDERMEERS AND J. CHRISTOPHE. Eur. J. Biochem. 195 535-541 (1991).
30. P. ROBBERECHT, P. COURLET, P. DE NEEF, M. C. WOUSSEN-COLLE, M. C. VANDERMEERS-PIRET, A. VANDERMEERS and J. CHRISTIPHE. Eur. J. Biochem. 207 239-246 (1992).